Please join us for the next edition of Reed Smith’s FDA webinar series, “CBD: What now?”, on Wednesday, October 30, 2019 at 12:00 PM ET. Cori Goldberg, Marc Hauser, and Adam Brownrout will offer a summary of current federal (FDA, USDA) and state regulations for CBD and CBD products, and what they mean for businesses. … Continue Reading
Following a recent fact-finding trip to Canada undertaken by three British MPs interested in understanding the effects of a more relaxed regulatory environment for cannabis, the MPs predicted the UK would legalize cannabis for adult use in the next decade. As the potential offered by the cannabis industry continues to intrigue more and more life … Continue Reading
The Food and Drug Administration (FDA) will hold a public hearing on May 31, 2019, “to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.”1 This offers those within the cannabis industry a unique opportunity to speak on their concerns and interests … Continue Reading
